Pfizer Secures $10 Billion Metsera Acquisition After Intense Bidding War With Novo Nordisk
In a $10 billion agreement, Pfizer Inc. has agreed to buy Metsera Inc., a weight-loss medication firm. This purchase comes after a heated bidding war with Novo Nordisk A/S, a rival pharmaceutical business. According to Bloomberg, this disclosure places Pfizer in a strong position to win the startup'